학술논문
Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
Document Type
Review Article
Author
Source
In Vaccine: X 7 August 2020 5
Subject
Language
ISSN
2590-1362